Data from individual cells holds the key to a longer & healthier life
Science Business - 17-Dec-2020Aim to intervene in ageing-related diseases before they cause harm. Sounds like curing ageing!
Join the club for FREE to access the whole archive and other member benefits.
Head of the Chromatin Dynamics team Research center of Institut Curie.
Geneviève ALMOUZNI, PhD was the Director of the Research Center of the Institut Curie –Paris, a major Cancer research center, between 2013 and 2018. She has been the head of the research Unit “Nuclear dynamics" (UMR3664 CNRS/Institut Curie) since 1999 developing work on genome organization and function.
Her scientific contribution has been central to define key mechanisms in chromatin assembly from the basic unit, the nucleosome, up to higher order structure in the nucleus. She has exploited various approaches from the development of in vitro systems, to the use of single molecules and analysis of nuclear architecture giving rise to series of publications (over 200 peer-reviewed papers). Her work has also addressed implication of these findings for cancer biology.
Her work has received continuous funding support, including ERC grants. Member of several international scientific advisory boards (EMBO Journal, Genes & Development, Cell, etc.) and recipient of several international grants (Human Science Frontier, several European grants (including ERC Advanced Grant), she received prestigious awards, most recently, Woman in Sciences FEBS /EMBO (2013), member of the Académie des Sciences (2013), and AAAS Fellow (American Association for the Advancement of Science, 2014). She was appointed as Vice-chair at the EMBO Council in 2014 and elected Co-Chair of EU-LIFE alliance.
Visit website: https://science.curie.fr/members/genevieve-almouzni/
See also: Institut Curie - Research center for biophysics, cell biology and oncology and a hospital specialized in treatment of cancer
Details last updated 18-Dec-2020
Aims to track, understand and target human cells during the onset and progression of complex diseases
Aim to intervene in ageing-related diseases before they cause harm. Sounds like curing ageing!